U.S. flag

An official website of the United States government

NM_020297.4(ABCC9):c.4352T>C (p.Val1451Ala) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 2, 2012
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000038617.5

Allele description [Variation Report for NM_020297.4(ABCC9):c.4352T>C (p.Val1451Ala)]

NM_020297.4(ABCC9):c.4352T>C (p.Val1451Ala)

Genes:
ABCC9:ATP binding cassette subfamily C member 9 [Gene - OMIM - HGNC]
KCNJ8-AS1:KCNJ8 antisense RNA 1 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p12.1
Genomic location:
Preferred name:
NM_020297.4(ABCC9):c.4352T>C (p.Val1451Ala)
HGVS:
  • NC_000012.12:g.21807443A>G
  • NG_012819.1:g.134252T>C
  • NM_001377273.1:c.4352T>C
  • NM_001377274.1:c.3485T>C
  • NM_005691.4:c.4352T>C
  • NM_020297.4:c.4352T>CMANE SELECT
  • NP_001364202.1:p.Val1451Ala
  • NP_001364203.1:p.Val1162Ala
  • NP_005682.2:p.Val1451Ala
  • NP_064693.2:p.Val1451Ala
  • NP_064693.2:p.Val1451Ala
  • LRG_377t2:c.4352T>C
  • LRG_377:g.134252T>C
  • NC_000012.11:g.21960377A>G
  • NM_005691.2:c.4352T>C
  • NM_020297.3:c.4352T>C
  • c.4352T>C
Protein change:
V1162A
Links:
dbSNP: rs397517190
NCBI 1000 Genomes Browser:
rs397517190
Molecular consequence:
  • NM_001377273.1:c.4352T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377274.1:c.3485T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005691.4:c.4352T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020297.4:c.4352T>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000062295Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(May 2, 2012)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000062295.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

The Val1451Ala variant (ABCC9) has not been reported in the literature nor previ ously identified by our laboratory. Computational analyses (biochemical amino ac id properties, conservation, AlignGVGD, and SIFT) suggest that the variant may i mpact the protein but PolyPhen-2 predicts it to be benign. However, though this information is not predictive enough to determine pathogenicity. In summary, add itional information is needed to fully assess the clinical significance of the V al1451Ala variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

Last Updated: Feb 25, 2025